26. september, 2025 Meddelelse BioPorto sponsorerer konferencer om pædiatrisk intensiv behandling med præsentation af nye videnskabelige data om NGAL KØBENHAVN, DANMARK og BOSTON, MA, USA, 26. september – BioPorto A/S (“BioPorto” eller “Selskabet”) ( …

… county’s fight against kidney-related diseases. The highly … game-changer in various treatment modalities, including hemodialysis and … are central to her development agenda Medical Services, Public … conditions to prevent further kidney failure,” she said. …

… by the US Food and Drug Administration (FDA).  The product is now … . This includes those with chronic kidney disease (CKD stages 3-5 … , and nails. People with chronic kidney disease, women who menstruate, those …

… access to Elamipretide, the FDA approved the medication. In August, his mother … way for more rare disease developments. This highlighted and underscored a … kidney function is getting better,” Wilson explained. “We know that this drug …

… turn, Hansa has developed imlifidase to rapidly cleave … treatment, Philipson explained. Patients on imlifidase achieved statistically significant improvements in kidney … endpoint. Hansa’s drug was well tolerated … through its clinical trials, providing a strong …

… far longer than in many developed markets. She said the lag … quality life from a new treatment. The white paper argues the … based pricing so multi-indication drugs are not forced into … for chronic kidney disease this summer.  Ofev (nintedanib), a drug for lung …

… greater risk for developing chronic kidney disease following cisplatin treatment. An analysis of … have chronic kidney disease prior to treatment, 13.6% developed it, including … other factors, such as concomitant medications and radiotherapy fields. Start …

… ; she explains. At 22, Vada developed high blood pressure, which was … remote deployments. "I had meds, but no one monitored my … at times, she took seven medications. "All these years, my … are two prime causes of kidney disease. But those don…

… randomized controlled trial (RCT). The trial protocol adhered to … group assignments and corresponding medications were sealed in sequentially … .13 Given the pharmacodynamic profile of liposomal … . Only one patient developed peripheral incisional numbness, …

Chronic Kidney Disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to function properly. Since kidneys play a vital role in filtering waste, balancing fluids, and regulating blood pressure, their decline can affect …